Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib 23 August 2020 | 11:09 Code : 11297 New Features Send To Others Your Name Your Email Recipient Email Send Cancel visits:18071 http://http://journal.waocp.org/article_88725.html
